Comprehensive investigation of the non-covalent binding of MRI contrast agents with human serum albumin.
about
Lanthanide probes for bioresponsive imagingGd(3+) complexes conjugated to Pittsburgh compound B: potential MRI markers of β-amyloid plaques.Ln[DO3A-N-α-(pyrenebutanamido)propionate] complexes: optimized relaxivity and NIR optical properties.Gd Complexes of DO3A-(Biphenyl-2,2'-bisamides) Conjugates as MRI Blood-Pool Contrast Agents.High relaxivity Mn(2+)-based MRI contrast agents.Assembly of near infra-red emitting upconverting nanoparticles and multiple Gd(III)-chelates as a potential bimodal contrast agent for MRI and optical imaging.Associating a negatively charged GdDOTA-derivative to the Pittsburgh compound B for targeting Aβ amyloid aggregates.Optical and relaxometric properties of monometallic (Eu(III), Tb(III), Gd(III)) and heterobimetallic (Re(I)/Gd(III)) systems based on a functionalized bipyridine-containing acyclic ligand.Thermodynamic stability and relaxation studies of small, triaza-macrocyclic Mn(II) chelates.Gadofosveset-based biomarker of tissue albumin concentration: Technical validation in vitro and feasibility in vivo.Strategies for the preparation of bifunctional gadolinium(III) chelators.Synthesis, relaxivity, and in vitro fluorescence imaging studies of a novel d-f heterometallic trinuclear complex as a potential bimodal imaging probe for MRI and optical imaging.Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRIStructural Features of Europium(II)-Containing Cryptates That Influence Relaxivity.Fluorometry, a fast screening technique for non-covalent binding of contrast agents to human serum albumin?
P2860
Q27000361-0A40E80F-B731-46E5-999C-83D90B6F30D7Q30706028-119A4F99-2969-4293-B44B-66267CA68E63Q30716845-EC56B946-BA20-44A9-93DB-5A5EC4A43721Q30829168-6198632F-0B07-40F3-B0BA-2D9F804A2209Q30868530-F120DBE7-271C-4C0B-A019-1D66B6797CACQ30958749-88C9E07D-232B-4FEE-A8D8-CDA6E28F8B88Q31028845-5E8BA3AC-3DCE-4D95-81AF-6D32ACB4DB2AQ31083784-57B35232-3782-49B1-806C-67EF1D5121DDQ34561711-AB4601AD-F9AE-44DF-8C4F-E1D387871DA6Q34974971-63CBC583-F512-4BEF-869E-C8FF3034B5F5Q35777941-DACAE4B9-2946-4820-8662-36402ACE5497Q35786129-6707F2C9-774F-4CF6-9F0B-348276167394Q36501363-1BF60755-D5DB-44B0-8658-B7680D6343EFQ38657746-20B1B369-F0F4-4F06-BB92-603572A367CEQ44401920-04745BDA-E526-41CB-AFEF-B8BDE1AC6FEB
P2860
Comprehensive investigation of the non-covalent binding of MRI contrast agents with human serum albumin.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Comprehensive investigation of ...... ents with human serum albumin.
@en
type
label
Comprehensive investigation of ...... ents with human serum albumin.
@en
prefLabel
Comprehensive investigation of ...... ents with human serum albumin.
@en
P2093
P1476
Comprehensive investigation of ...... ents with human serum albumin.
@en
P2093
Luce Vander Elst
Robert N Muller
Sophie Laurent
Virginie Henrotte
P2888
P304
P356
10.1007/S00775-007-0247-5
P577
2007-06-09T00:00:00Z